Adrian Owen & Faraz Shafaghi, Creyos
Key Takeaways
- •Creyos platform provides objective cognitive scores during Medicare wellness visits
- •Medicare now mandates baseline neurological testing for annual wellness exams
- •Platform integrates with EHRs for real‑time point‑of‑care data capture
- •CEO says early detection can reduce long‑term care costs
- •Roadmap adds AI‑driven risk stratification for dementia prediction
Pulse Analysis
Cognitive health is emerging as a cornerstone of preventive medicine, and recent Medicare policy changes reflect that shift. By mandating baseline neurological testing as part of the annual wellness visit, the government is encouraging early detection of cognitive decline, a move that could curb the rising costs associated with dementia care. This regulatory backdrop creates a fertile environment for companies that can deliver reliable, point‑of‑care assessments, and Creyos is positioned to meet that demand.
Creyos’ platform combines a brief, tablet‑based test with seamless integration into electronic health records, allowing clinicians to capture objective cognitive scores during a routine visit. The data are instantly available for interpretation, enabling physicians to flag subtle changes that might otherwise go unnoticed. Early identification of impairment not only improves patient outcomes through timely intervention but also informs care pathways, potentially reducing the need for expensive specialist referrals and long‑term care services.
The broader market implications are significant. As insurers and health systems seek cost‑effective ways to manage an aging population, scalable solutions like Creyos become attractive partners. The company’s roadmap, which includes AI‑driven risk stratification for dementia, promises to enhance predictive analytics and personalize care plans. If adoption accelerates, Creyos could become a primary source of neurological data, influencing everything from clinical guidelines to reimbursement models, and cementing its role in the evolving health‑tech ecosystem.
Adrian Owen & Faraz Shafaghi, Creyos
Comments
Want to join the conversation?